Welcome to Xi’an Good Doctor Medical Science and Technology Co., Ltd.website !
Tel: +86 29 82681864
+86 15002902555
Internet Drug Information Service Qualification Certificate: (Shaanxi)-Non-Operating -2023-0143
Home
About
Company Profile
Culture
Patent technology
Domestic Patent
Foreign patents
Professional Academic
Clinical base
Thermotherapy Special Topic
Clinical Application - Internal Medicine
Clinical Application - Surgery
Animal Experimentation
Products
Cavity Thermal Perfusion Treatment Machine
Medical consumables
Blog
Corporate News
Industry News
Notice Announcement
Investment Cooperation
Franchise
After-sale Service
Market Distribution
Contact
Contact information
Talent Jobs
Expert Guidance
中
——
2024.09.27
Good Doctor·Hot Infusion | Hand in hand for over a decade, the boundless love behind the technical discourse.
They are pioneers in the field of tumor hyperthermia in our country and practitioners of dreams. Their mission is to improve the quality of life for cancer patients, embarking on the journey of developing intraperitoneal hyperthermia treatment machines. They are the Good Doctor team, a group of indomitable dream chasers. Through their actions, they interpret persistence and dedication, painting a hopeful picture for the field of tumor hyperthermia treatment in our country.
2026.05.06
Good Doctor·Hyperthermic Perfusion | Bringing the “Effective Treatment Temperature” Truly into Hyperthermia Clinical Practice
2026.04.20
Good Doctor·Hyperthermic Perfusion | The “Elite Pursuit of Excellence” Furnace Program — Standardized Training on Cavity Hyperthermic Perfusion Therapy, Session 3 of 2026 (Overall Session 7) (Xi’an Headquarters) Concluded Successfully
2026.04.13
Good Doctor·Hyperthermic Perfusion | “Elite Pursuit of Excellence” Furnace Program — The 2026 Standardized Spring Training Camp on Body Cavity Hyperthermic Perfusion Therapy (Shanxi Station) Concludes Successfully
“Empowering Clinical Practice, Jointly Driving Development.” Recently, the two-day “Elite Pursuit of Excellence” Melting Pot Program—the 2026 Standardized Spring Training Camp on Intraperitoneal Hyperthermic Perfusion Therapy (Shanxi Station)—concluded successfully in Taiyuan. Clinical experts from the front lines across Shanxi Province gathered to jointly explore and refine techniques, thereby advancing diagnostic and therapeutic practices. This milestone marks a new phase in the standardized promotion of intraperitoneal hyperthermic perfusion therapy (HIPEC) throughout the Shanxi region.
2026.03.22
Good Doctor·Hyperthermic Perfusion | The First Session of Standardized Clinical Application Training for Hyperthermic Perfusion Therapy Machines in 2026 Concludes Successfully
From March 21 to 22, 2026, the first session of the 2026 Standardized Clinical Application Training on GD Hyperthermic Perfusion Therapy Devices successfully concluded. Medical professionals and partners from across the country gathered to enhance their skills through learning and to drive improvement through exchange, thereby injecting new momentum into the standardized development of hyperthermic perfusion therapy for cancer.
2026.03.20
Good Doctor·Hyperthermic Perfusion | The Hazards of Malignant Ascites and a Core Analysis of Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Cancerous ascites, also known as malignant ascites, is a pathological condition in which malignant tumors invade intra-abdominal organs and metastasize to the retroperitoneum, leading to an abnormal increase and accumulation of fluid within the peritoneal cavity. It is a common complication of advanced malignancies, such as gastric cancer, colorectal cancer, ovarian cancer, and pancreatic cancer. Cancerous ascites severely impairs patients’ quality of life, accelerates disease progression, and serves as a significant indicator of poor prognosis in patients with advanced cancer. According to clinical data, approximately 15%–20% of patients with advanced malignancies develop cancerous ascites, with the highest incidence observed in ovarian and gastric cancer—ranging from 50%–70% and 30%–40%, respectively. Among patients with advanced cancer complicated by cancerous ascites, the median survival is typically less than six months.
2026.02.27
Good Doctor: Hot Infusion | United in Purpose, Striving for New Success—Spring Empowerment Training for 2026
The New Year ushers in a new beginning, and now is the time to forge ahead with determination. To further implement the company’s management system, enhance the overall competence and professional skills of all employees, and support the company’s steady development, on February 25, 2026, Good Doctor organized the “Unite as One, Forge Ahead for Mutual Success—2026 Spring Empowerment Training.” All employees gathered together to learn and grow side by side, using learning to fuel personal growth and training to drive practical action. United in purpose, we set out on a new journey of vigorous advancement for the coming year.
2026.02.13
Good Doctor – Thermal Perfusion | United in Solidarity, Embarking on a New Journey
As the year draws to a close and the new year begins, today’s 2025 Chairman’s Work Report and Annual Excellence Awards Ceremony concluded successfully. All company employees gathered together to jointly review the journey and remarkable achievements of 2025, recognize outstanding individuals, unite our strengths, and look forward to writing a new chapter in our future development.